First Header Logo Second Header Logo

Sally Shumaker

Concepts (216)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Women's Health
20
2019
226
4.110
Why?
Cognition
17
2019
526
2.130
Why?
Aging
9
2016
883
2.010
Why?
Estrogen Replacement Therapy
15
2017
182
1.670
Why?
Estrogens, Conjugated (USP)
12
2017
125
1.630
Why?
Postmenopause
19
2019
398
1.360
Why?
Quality of Life
13
2016
824
1.200
Why?
Cognition Disorders
11
2019
390
1.180
Why?
Hormone Replacement Therapy
6
2019
86
1.060
Why?
Disability Evaluation
2
2016
211
1.010
Why?
Activities of Daily Living
6
2016
240
1.000
Why?
Dementia
7
2019
234
0.960
Why?
Geriatric Assessment
2
2016
356
0.940
Why?
Medroxyprogesterone Acetate
8
2017
89
0.870
Why?
Female
49
2019
18270
0.830
Why?
Memory
6
2017
187
0.770
Why?
Health Status
11
2016
370
0.760
Why?
Humans
56
2019
29294
0.700
Why?
Sleep Initiation and Maintenance Disorders
3
2005
49
0.690
Why?
Diabetic Neuropathies
1
2019
23
0.680
Why?
Aged
39
2019
9528
0.660
Why?
Affect
3
2018
64
0.650
Why?
Neuralgia
1
2019
48
0.650
Why?
Aged, 80 and over
13
2019
3729
0.640
Why?
United States
14
2018
3655
0.580
Why?
Motor Activity
3
2016
311
0.560
Why?
Neuropsychological Tests
11
2019
379
0.550
Why?
Polysomnography
1
2016
33
0.550
Why?
Tamoxifen
3
2012
48
0.550
Why?
Sleep Apnea, Obstructive
1
2016
47
0.540
Why?
Independent Living
1
2016
79
0.530
Why?
Patient Dropouts
1
2015
24
0.520
Why?
Diabetes Mellitus, Type 2
2
2019
1385
0.490
Why?
Geriatrics
1
2015
94
0.490
Why?
Patient Compliance
1
2015
212
0.450
Why?
Depression
6
2012
386
0.450
Why?
Cardiovascular Diseases
4
2018
1022
0.440
Why?
Randomized Controlled Trials as Topic
6
2019
467
0.440
Why?
Selective Estrogen Receptor Modulators
2
2010
29
0.440
Why?
Psychotic Disorders
1
2012
10
0.430
Why?
Antipsychotic Agents
1
2012
26
0.430
Why?
Schizophrenia
1
2012
38
0.430
Why?
Middle Aged
27
2019
10892
0.420
Why?
Adaptation, Psychological
3
2019
126
0.420
Why?
Estrogens
6
2013
163
0.400
Why?
Medroxyprogesterone
2
2017
12
0.400
Why?
Women's Health Services
2
2013
9
0.390
Why?
Breast Neoplasms
4
2012
673
0.390
Why?
Health Surveys
3
2016
191
0.390
Why?
Academic Medical Centers
2
2016
150
0.380
Why?
Progesterone Congeners
3
2006
15
0.360
Why?
Cohort Studies
5
2016
1697
0.310
Why?
Risk Factors
10
2019
3560
0.300
Why?
Proportional Hazards Models
5
2018
710
0.290
Why?
Memory Disorders
2
2017
61
0.280
Why?
Training Support
1
2006
5
0.280
Why?
Research Support as Topic
1
2006
25
0.280
Why?
Incidence
5
2019
1123
0.270
Why?
Double-Blind Method
8
2019
504
0.270
Why?
Faculty, Medical
1
2006
69
0.260
Why?
Psychiatric Status Rating Scales
1
2005
93
0.250
Why?
Psychometrics
4
2012
129
0.240
Why?
Multicenter Studies as Topic
1
2004
93
0.230
Why?
Factor Analysis, Statistical
3
2012
70
0.230
Why?
Sickness Impact Profile
1
2003
35
0.220
Why?
Reproducibility of Results
4
2012
727
0.220
Why?
Health Services Research
1
2003
79
0.210
Why?
Clinical Trials as Topic
3
2013
299
0.200
Why?
Finasteride
2
2012
12
0.190
Why?
Cause of Death
2
2018
221
0.190
Why?
Self Care
2
2016
137
0.180
Why?
Cacao
1
2019
4
0.180
Why?
Dietary Supplements
2
2019
170
0.180
Why?
Treatment Outcome
8
2017
3116
0.170
Why?
Risk
5
2017
290
0.170
Why?
Vitamins
1
2019
59
0.170
Why?
Plant Extracts
1
2019
60
0.170
Why?
Qualitative Research
1
2019
142
0.160
Why?
Survival Analysis
2
2018
440
0.160
Why?
Alzheimer Disease
2
2019
312
0.160
Why?
Depressive Disorder
1
2018
74
0.150
Why?
Risk Assessment
2
2018
1316
0.150
Why?
Predictive Value of Tests
2
2018
792
0.150
Why?
Androgens
1
2017
22
0.150
Why?
Particulate Matter
1
2017
30
0.150
Why?
Testosterone
1
2017
48
0.140
Why?
Mortality
1
2017
110
0.140
Why?
Caffeine
1
2016
31
0.140
Why?
Placebos
3
2007
61
0.140
Why?
Age Factors
3
2005
1115
0.140
Why?
Environmental Exposure
1
2017
87
0.140
Why?
Decision Making, Organizational
1
2016
4
0.140
Why?
Magnetic Resonance Imaging
2
2014
1221
0.140
Why?
Oximetry
1
2016
28
0.140
Why?
Ethnic Groups
3
2018
440
0.140
Why?
Interdisciplinary Communication
1
2016
53
0.130
Why?
Male
9
2019
17896
0.130
Why?
Automobile Driving
1
2015
24
0.130
Why?
Prostatic Neoplasms
2
2012
442
0.130
Why?
Genetic Predisposition to Disease
1
2019
838
0.130
Why?
Life Style
2
2016
364
0.130
Why?
Burnout, Professional
1
2016
44
0.130
Why?
Feasibility Studies
1
2016
268
0.130
Why?
Demography
1
2015
104
0.130
Why?
Anticarcinogenic Agents
2
2012
24
0.130
Why?
Health Status Indicators
1
2015
67
0.130
Why?
Adult
5
2012
8484
0.130
Why?
Research Design
4
2004
287
0.130
Why?
Progestins
2
2005
18
0.120
Why?
Biomedical Research
1
2016
154
0.120
Why?
Hysterectomy
1
2013
37
0.110
Why?
Sampling Studies
2
2003
40
0.110
Why?
Refusal to Participate
1
2013
4
0.110
Why?
Population Surveillance
2
2003
119
0.110
Why?
Heart Failure
1
2018
573
0.110
Why?
Telephone
1
2012
50
0.110
Why?
Focus Groups
1
2012
104
0.100
Why?
Longitudinal Studies
5
2018
725
0.100
Why?
Patient Selection
1
2013
257
0.100
Why?
Severity of Illness Index
2
2012
864
0.100
Why?
Learning
1
2011
76
0.090
Why?
Medication Adherence
1
2012
144
0.090
Why?
Bone Density Conservation Agents
1
2008
20
0.080
Why?
Calcium, Dietary
1
2008
23
0.080
Why?
Antineoplastic Agents
1
2012
547
0.080
Why?
Hot Flashes
2
2005
46
0.080
Why?
Vitamin D
1
2008
173
0.070
Why?
Erectile Dysfunction
1
2007
48
0.070
Why?
Brain
1
2014
930
0.070
Why?
North Carolina
2
2012
1426
0.070
Why?
Financing, Organized
1
2006
14
0.070
Why?
Budgets
1
2006
10
0.070
Why?
Prospective Studies
5
2012
2035
0.070
Why?
Benchmarking
1
2006
25
0.070
Why?
Schools, Medical
1
2006
42
0.070
Why?
Program Evaluation
1
2006
175
0.070
Why?
Drug Labeling
1
2005
3
0.070
Why?
Norethindrone
1
2005
1
0.060
Why?
Drug Industry
1
2005
14
0.060
Why?
National Institutes of Health (U.S.)
1
2005
29
0.060
Why?
United States Food and Drug Administration
1
2005
44
0.060
Why?
Osteoarthritis, Knee
1
2005
80
0.060
Why?
Follow-Up Studies
3
2017
2117
0.060
Why?
Administration, Cutaneous
1
2005
107
0.060
Why?
Estradiol
1
2005
118
0.060
Why?
Menopause
1
2005
86
0.060
Why?
Cross-Sectional Studies
4
2015
1371
0.060
Why?
Attitude of Health Personnel
1
2005
163
0.060
Why?
Linear Models
3
2012
427
0.060
Why?
Exercise Therapy
1
2005
230
0.060
Why?
Coronary Artery Bypass
1
2003
100
0.060
Why?
Physicians
1
2005
135
0.060
Why?
Coronary Disease
1
2003
200
0.050
Why?
Continental Population Groups
2
2018
221
0.050
Why?
Coronary Artery Disease
1
2003
361
0.040
Why?
LDL-Receptor Related Proteins
1
2019
7
0.040
Why?
Catechol O-Methyltransferase
1
2019
14
0.040
Why?
Membrane Transport Proteins
1
2019
34
0.040
Why?
Renal Dialysis
1
2002
265
0.040
Why?
Brain-Derived Neurotrophic Factor
1
2019
36
0.040
Why?
Intracellular Signaling Peptides and Proteins
1
2019
72
0.040
Why?
Apolipoproteins E
1
2019
97
0.040
Why?
Mental Health
2
2012
104
0.040
Why?
Socioeconomic Factors
2
2013
394
0.040
Why?
Time Factors
2
2017
2009
0.040
Why?
Contraceptive Agents, Female
1
2017
15
0.040
Why?
Intention to Treat Analysis
1
2017
23
0.040
Why?
Cerebrum
1
2017
6
0.040
Why?
Neurites
1
2017
8
0.040
Why?
Gels
1
2017
33
0.040
Why?
Receptors, AMPA
1
2017
14
0.040
Why?
Atrophy
1
2017
51
0.040
Why?
CA1 Region, Hippocampal
1
2017
26
0.040
Why?
Kidney Failure, Chronic
1
2002
522
0.040
Why?
Executive Function
1
2017
54
0.040
Why?
Mental Recall
1
2017
52
0.040
Why?
Apolipoprotein E4
1
2017
58
0.040
Why?
Reference Values
1
2017
224
0.040
Why?
Mice, Transgenic
1
2017
249
0.030
Why?
Professional Autonomy
1
2016
6
0.030
Why?
Organizational Objectives
1
2016
22
0.030
Why?
Organizational Culture
1
2016
26
0.030
Why?
African Americans
2
2018
1373
0.030
Why?
Proxy
1
2015
9
0.030
Why?
Psychological Tests
1
2015
33
0.030
Why?
Polymorphism, Single Nucleotide
1
2019
1079
0.030
Why?
Cell Line, Tumor
1
2017
683
0.030
Why?
Statistics as Topic
2
2004
107
0.030
Why?
Organ Size
1
2014
196
0.030
Why?
Research Subjects
1
2013
28
0.030
Why?
Social Support
2
2003
165
0.030
Why?
Regression Analysis
2
2003
274
0.030
Why?
Odds Ratio
1
2013
448
0.030
Why?
Models, Statistical
1
2012
164
0.030
Why?
Neoplasms
1
2017
620
0.020
Why?
Single-Blind Method
1
2011
166
0.020
Why?
Mice
1
2017
2380
0.020
Why?
Logistic Models
1
2013
729
0.020
Why?
Pilot Projects
1
2011
483
0.020
Why?
Cholestenone 5 alpha-Reductase
1
2007
2
0.020
Why?
Fractures, Bone
1
2008
150
0.020
Why?
Enzyme Inhibitors
1
2007
162
0.020
Why?
Animals
1
2017
7318
0.020
Why?
Progesterone
1
2004
80
0.010
Why?
Income
1
2003
52
0.010
Why?
Antidepressive Agents
1
2004
71
0.010
Why?
Quality Assurance, Health Care
1
2003
62
0.010
Why?
Data Collection
1
2003
163
0.010
Why?
Urinary Incontinence
1
2003
45
0.010
Why?
Feeding Behavior
1
2003
159
0.010
Why?
Sexual Behavior
1
2003
98
0.010
Why?
Dose-Response Relationship, Drug
1
2004
641
0.010
Why?
Sex Factors
1
2003
632
0.010
Why?
Health Behavior
1
2003
216
0.010
Why?
Prevalence
1
2004
908
0.010
Why?
Exercise
1
2004
595
0.010
Why?
Shumaker's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (216)
Explore
_
Co-Authors (24)
Explore
_
Similar People (52)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_